This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,597.37 firm fixed-price delivery order is for the supply of Celecoxib 200 mg capsules, a medication used to treat pain and inflammation. The contract has an ultimate completion date of August 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,674.63, is for the delivery of Celebrex 200 mg capsules to support military healthcare programs. It is a firm-fixed price delivery order contract with a completion date of June 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,050.78, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of Celecoxib 200mg medication, a non-set-aside requirement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQEVU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,434.56 firm fixed-price delivery order is for the supply of 4568142809 Celecoxib 200 mg capsules, and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $4,969.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CELEBREX 100 MG CAPSULE 100S, a pharmaceutical product, with a completion date of May 21, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,714.56 firm fixed-price delivery order is for the supply of Celecoxib 200mg tablets, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,129.50 delivery order covers the supply of CELEBREX 200 MG CAPSULE UD 100S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
This delivery order for Celecoxib 100 mg capsules was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation on October 11, 2023. The order is for 500 capsules with a firm fixed price of $61 and has an anticipated completion date of October 12, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing prime vendor contract vehicle held...
<p>This delivery order for Celecoxib 100 mg capsules was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation. The order is for one hundred capsules with a potential value of thirty-eight dollars. Performance will take place in Conshohocken, Pennsylvania by October 2023. No set-aside designation was used for this firm fixed price order to supply pharmaceutical products in support of Defense Logistics Agency procurement programs.</p>
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,508.13 and a performance period through May 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...